Founded in 1998, Gan&Lee Pharmaceuticals is a high-tech biopharmaceutical company integrating R&D, production and commercialization. Headquatered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters and more than 4000 employees. As the first Chinese company with the technology of recombinant insulin analogues, Gan & Lee is definitely a market leader in China. Globally, Gan & Lee has established close collaboration with famous enterprises like Sandoz. Today, focusing on human healthcare, Gan & Lee is committed to providing high-quality products and services for diabetes patients worldwide.
Year Established: 1998
Total Number of Staff: more than 1000
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Reputation,Quality Service
Business Type: Manufacturer
R&D Capacity: OEM,Own Brand
Annual Turnover(USD) : More than 99,999,999
Main Sales Markets : Central/South America,Asia,Middle East
Subscribe to the latest newsletter of Virtual Expo Connect
pre-filled pen parts(disposable)
GanleeFine®(pen injeciton needle)
GanleePen™ (reusable insulin pen)
Similin® 30(insulin human 30 injection)